In my last column about the Novo Nordisk Foundation, I wrote about the company’s efforts in anti-microbial resistance, an example of an area where impact investment was necessary to combat market ...
Cellular Origins is transforming scalable cell therapy manufacture with robotic automation, reducing labour and enabling ...
The production-linked incentive (PLI) scheme has created over 1.33 million jobs in India's electronics industry and ...
BlueBird 6 is a breakthrough moment for AST SpaceMobile. This mission validates years of US innovation and manufacturing and ...
Celularity Inc. (Nasdaq: CELU) (“Celularity”), a regenerative and cellular medicine company addressing age-related and degenerative diseases, today released comments by Robert J. Hariri, M.D., Ph.D., ...
The cellular therapy landscape continues to evolve beyond hematologic malignancies, now making significant progress in solid ...
Regenerative medicine has begun to influence aesthetic and dermatological practice in ways that extend beyond the realm of ...
The Bluebird Block-2, launched by ISRO, is the largest commercial communications satellite in Low Earth Orbit, expected to ...
Bluebird Block-2 satellite to begin operations soon after successful launch by ISRO. AST SpaceMobile aims for global ...
AST SpaceMobile, Inc. ("AST SpaceMobile") (NASDAQ: ASTS), the company building the first and only space-based cellular ...
The company plans to announce Phase 1b interim data by mid-2026, and the TENACITY-01 study is expected to be completed by late 2028. This timing enables progression to Phase 2 evaluation following ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback